AI developer Paige scores CE marks in breast, prostate cancers
Digital pathology developer Paige has received two European approvals for its artificial-intelligence-powered diagnostic platforms in breast and prostate cancers. One CE mark covers breast cancer detection software that automatically highlights suspicious areas on slides of biopsied breast tissue for further review, while a second greenlights software to help rate prostate tumor samples, deliver a prognosis and guide treatment planning.
#ai/software